Reduction of cyclosporine after introduction of mycophenolate mofetil improves chronic renal dysfunction in heart transplant recipients - The IMPROVED multi-centre study

European Heart Journal

Volumn 25, Issue 18, 2004, Pages 1626-1634

  Angermann, Christiane E ^a   Störk, Stefan ^a   Costard Jäckle, Angelika ^b   Dengler, Thomas J ^c   Siebert, Uwe ^d   Tenderich, Gero ^e   Rahmel, Axel ^f   Schwarz, Ernst R ^g,h   Nägele, Herbert ⁱ   Wagner, Florian M ^j   Haaff, Bernd ^k   Pethig, Klaus ^l  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d HARVARD MEDICAL SCHOOL   (United States)

^e RUHR UNIVERSITY BOCHUM   (Germany)

^f UNIVERSITY OF LEIPZIG   (Germany)

^g RWTH AACHEN UNIVERSITY   (Germany)

^h UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

ⁱ Germany   (Germany)

^j University Heart Center Dresden   (Germany)

^k Westpfalz Klinikum GmbH   (Germany)

^l Klinik für Thorax Herz und Gefäßchirurgie   (Germany)

more..

Author keywords

Chronic renal failure; Cyclosporine; Heart transplantation; Mycophenolate mofetil

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; SANDIMMUN OPTORAL; STEROID;

ADULT; AGED; ARTICLE; BIOPSY; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; GRAFT FAILURE; HEART MUSCLE; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE REGRESSION; PRIORITY JOURNAL; SIDE EFFECT;

CYCLOSPORINE; FEMALE; HEART DISEASES; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 20844432212     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2004.06.032     Document Type: Article

References (24)

1. V. Sehgal, J. Radhakrishnan, and G.B. Appel Progressive renal insufficiency following cardiac transplantation: cyclosporine, lipids, and hypertension Am J. Kidney Dis. 26 1995 193 201
2. D.J. Goldstein, N. Zuech, and V. Sehgal Cyclosporine-associated end-stage nephropathy after cardiac transplantation: incidence and progression Transplantation 63 1997 664 668
3. J. Hornberger, J. Best, and J. Geppert Risks and costs of end-stage renal disease after heart transplantation Transplantation 66 1998 1763 1770
4. G. Parry, B. Meiser, and G. Rabago The clinical impact of cyclosporine nephrotoxicity in heart transplantation Transplantation 69 2000 S23 S26
5. W.D. Simmons, S.C. Rayhill, and H.W. Sollinger Preliminary risk-benefit assessment of mycophenolate mofetil in transplant rejection Drug Saf. 17 1997 75 92
6. J. Kobashigawa, L. Miller, and D. Renlund A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators Transplantation 66 1998 507 515
7. A. Keogh, R. Bourge, and M. Costanzo Three year results of the double-blind randomized multicenter trial of mycophenolate mofetil in heart transplant patients J. Heart Lung Transplant. 18 Abstract 1999 53
8. J.D. Hosenpud, and L.E. Bennett Mycophenolate mofetil versus azathioprine in patients surviving the initial cardiac transplant hospitalization: an analysis of the Joint UNOS/ISHLT Thoracic Registry Transplantation 72 2001 1662 1665
9. G. Mourad, C. Vela, and J. Ribstein Long-term improvement in renal function after cyclosporine reduction in renal transplant recipients with histologically proven chronic cyclosporine nephropathy Transplantation 65 1998 661 667
10. T. van Gelder, L.B. Hilbrands, and Y. Vanrenterghem A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation Transplantation 68 1999 261 266
11. H.J. Schlitt, A. Barkmann, and K.H. Boker Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study Lancet 357 2001 587 591
12. M.R. Weir, M.T. Ward, and S.A. Blahut Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy Kidney Int. 59 2001 1567 1573
13. D.K. Satchithananda, J. Parameshwar, and L. Sharples The incidence of end-stage renal failure in 17 years of heart transplantation: a single center experience J. Heart Lung Transplant. 21 2002 651 657
14. I. Aleksic, M. Baryalei, and T. Busch Improvement of impaired renal function in heart transplant recipients treated with mycophenolate mofetil and low-dose cyclosporine Transplantation 69 2000 1586 1590
15. G. Dureau, J.F. Obadia, and M. Chuzel Introduction of mycophenolate mofetil and cyclosporine withdrawal in heart transplant patients with progressive deteriorating renal function Transplant Proc. 32 2000 461 462
16. T. Tedoriya, A.M. Keogh, and K. Kusano Reversal of chronic cyclosporine nephrotoxicity after heart transplantation-potential role of mycophenolate mofetil J. Heart Lung Transplant. 21 2002 976 982
17. W.E. Mitch, M. Walser, and G.A. Buffington A simple method of estimating progression of chronic renal failure Lancet 2 1976 1326 1328
18. L. Oldrizzi, C. Rugiu, and E. Valvo Progression of renal failure in patients with renal disease of diverse etiology on protein-restricted diet Kidney Int. 27 1985 553 557
19. V.B. Delaney, S. Adler, and F.J. Bruns Autosomal dominant polycystic kidney disease: presentation, complications, and prognosis Am. J. Kidney Dis. 5 1985 104 111
20. D.W. Cockcroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
21. M.E. Billingham, N.R. Cary, and M.E. Hammond A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation J. Heart Transplant. 9 1990 587 593
22. R.A. Little Regression with missing X's: a review J. Am. Stat. Assoc. 87 1992 1227 1237
23. S. Greenland, and W.D. Finkle A critical look at methods for handling missing covariates in epidemiologic regression analyses Am. J. Epidemiol. 142 1995 1255 1264
24. R. Klingenberg, A. Koch, and P.A. Schnabel Allograft rejection of ISHLT grade ≥3A occurring late after heart transplantation - a distinct entity J. Heart Lung Transplant. 22 2003 1005 1013